ProKidney (NASDAQ:PROK) Trading Down 0.7% - Time to Sell?Market Beat·Jul 24 at 01:20 AMPROK+3.67%JPM+0.70%
US Micro-Caps and Legacy Equities Navigate 2026 Strategic ShiftsGlobal Report·Jul 22 at 04:18 AMPROK+3.67%FNMA-1.93%
ProKidney Highlights Progress in Pivotal Phase 3 CKD TrialTip Ranks·May 15 at 11:20 AMPROK+3.67%BBH+0.58%
ProKidney | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 226 KEarnings Watch·May 15 at 10:51 AMPROK+3.67%
PROKIDNEY CORP. 1Q 2026: Revenue $0.226M, EPS $(0.14) — 10-Q SummaryTradingView·May 15 at 10:51 AMPROK+3.67%SBIO+1.42%
ProKidney Reports First Quarter 2026 Financial Results and Business Highlights | PROK Stock NewsStockTitan·May 15 at 02:45 AMPROK+3.67%BIB+0.90%
ProKidney | 10-K: FY2025 Revenue Beats Estimate at USD 893 KEarnings Watch·Apr 24 at 05:33 AMPROK+3.67%
ProKidney (NASDAQ:PROK) Trading Down 7.6% - Here's What HappenedMarket Beat·Mar 24 at 02:28 PMLABU+0.98%IBB+0.23%
